These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19039990)

  • 21. Restless Legs Syndrome and Restless Sleep Disorder in Children.
    DelRosso LM; Mogavero MP; Bruni O; Ferri R
    Sleep Med Clin; 2023 Jun; 18(2):201-212. PubMed ID: 37120162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopa responsive insomnia: a forme fruste or precursor of restless legs syndrome?
    Prakash S
    J Neurol Sci; 2012 May; 316(1-2):170-2. PubMed ID: 22349357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early manifestations of restless legs syndrome in childhood and adolescence.
    Picchietti DL; Stevens HE
    Sleep Med; 2008 Oct; 9(7):770-81. PubMed ID: 18024165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Restless legs syndrome in women: a review.
    Thomas K; Watson CB
    J Womens Health (Larchmt); 2008 Jun; 17(5):859-68. PubMed ID: 18537487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CSF iron, ferritin and transferrin levels in restless legs syndrome.
    Mizuno S; Mihara T; Miyaoka T; Inagaki T; Horiguchi J
    J Sleep Res; 2005 Mar; 14(1):43-7. PubMed ID: 15743333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compulsive habits in restless legs syndrome patients under dopaminergic treatment.
    Pourcher E; Rémillard S; Cohen H
    J Neurol Sci; 2010 Mar; 290(1-2):52-6. PubMed ID: 19969309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Critical review of ropinirole and pramipexole - putative dopamine D(3)-receptor selective agonists - for the treatment of RLS.
    Varga LI; Ako-Agugua N; Colasante J; Hertweck L; Houser T; Smith J; Watty AA; Nagar S; Raffa RB
    J Clin Pharm Ther; 2009 Oct; 34(5):493-505. PubMed ID: 19744006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of oral iron treatment in pediatric restless legs syndrome (RLS).
    Mohri I; Kato-Nishimura K; Kagitani-Shimono K; Kimura-Ohba S; Ozono K; Tachibana N; Taniike M
    Sleep Med; 2012 Apr; 13(4):429-32. PubMed ID: 22341906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term open-label study of pramipexole in patients with primary restless legs syndrome.
    Inoue Y; Kuroda K; Hirata K; Uchimura N; Kagimura T; Shimizu T
    J Neurol Sci; 2010 Jul; 294(1-2):62-6. PubMed ID: 20451927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of childhood-onset restless legs syndrome and periodic limb movement disorder using intravenous iron sucrose.
    Grim K; Lee B; Sung AY; Kotagal S
    Sleep Med; 2013 Nov; 14(11):1100-4. PubMed ID: 23993871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Night-to-night variability of periodic leg movements during sleep in restless legs syndrome and periodic limb movement disorder: comparison between the periodicity index and the PLMS index.
    Ferri R; Fulda S; Manconi M; Högl B; Ehrmann L; Ferini-Strambi L; Zucconi M
    Sleep Med; 2013 Mar; 14(3):293-6. PubMed ID: 23068780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic dopaminergic treatment in restless legs syndrome: does it affect the autonomic nervous system?
    Rocchi C; Albanese M; Placidi F; Romigi A; Lauretti B; Marfia GA; Liguori C; Marciani MG; Mercuri NB; Izzi F
    Sleep Med; 2015 Sep; 16(9):1071-6. PubMed ID: 26298781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome: A polysomnographic randomized, double-blind, placebo-controlled study.
    Inoue Y; Hirata K; Kuroda K; Fujita M; Shimizu T; Emura N; Uchimura N; Kagimura T; Sha K; Nozawa T
    Sleep Med; 2010 Jan; 11(1):11-6. PubMed ID: 19962941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Internal medicine: guidance to the diagnosis and management of restless legs syndrome.
    Ball E; Caivano CK
    South Med J; 2008 Jun; 101(6):631-4. PubMed ID: 18475241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spectrum of sleep disorders in a patient with spinocerebellar ataxia 13.
    Kapoor M; Greenough G
    J Clin Sleep Med; 2015 Jan; 11(2):177-9. PubMed ID: 25406272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of restless legs syndrome and iron deficiency on attention-deficit/hyperactivity disorder in children.
    Konofal E; Cortese S; Marchand M; Mouren MC; Arnulf I; Lecendreux M
    Sleep Med; 2007 Nov; 8(7-8):711-5. PubMed ID: 17644481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Restless legs syndrome in older adults.
    Spiegelhalder K; Hornyak M
    Clin Geriatr Med; 2008 Feb; 24(1):167-80, ix. PubMed ID: 18035239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnosis and novel treatment approaches in restless legs syndrome: II. Treatment].
    Hirata K; Suzuki K
    Brain Nerve; 2013 Nov; 65(11):1391-9. PubMed ID: 24200617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restless legs syndrome.
    Ekbom K; Ulfberg J
    J Intern Med; 2009 Nov; 266(5):419-31. PubMed ID: 19817966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polysomnographic record and successful management of augmentation in restless legs syndrome/Willis-Ekbom disease.
    Maestri M; Fulda S; Ferini-Strambi L; Zucconi M; Marelli S; Staedler C; Bassetti CL; Manconi M
    Sleep Med; 2014 May; 15(5):570-5. PubMed ID: 24767724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.